---
title: "Design Therapeutics to Host Investor Webcast to Review Data from RESTORE-FA Trial of DT-216P2 for Friedreich’s Ataxia on Monday, May 18, 2026 | DSGN Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286681555.md"
description: "Design Therapeutics to Host Investor Webcast to Review Data from RESTORE-FA Trial of DT-216P2 for Friedreich’s Ataxia on Monday, May 18, 2026 | DSGN Stock News"
datetime: "2026-05-17T12:00:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286681555.md)
  - [en](https://longbridge.com/en/news/286681555.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286681555.md)
---

# Design Therapeutics to Host Investor Webcast to Review Data from RESTORE-FA Trial of DT-216P2 for Friedreich’s Ataxia on Monday, May 18, 2026 | DSGN Stock News

Design Therapeutics to Host Investor Webcast to Review Data from RESTORE-FA Trial of DT-216P2 for Friedreich’s Ataxia on Monday, May 18, 2026 | DSGN Stock News

### Related Stocks

- [DSGN.US](https://longbridge.com/en/quote/DSGN.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)

## Related News & Research

- [Jim Cramer: Design Therapeutics Is 'Pure Spec,' Buy This Health Care Stock](https://longbridge.com/en/news/286561214.md)
- [ImmunityBio reports higher complete response rates for ANKTIVA plus BCG in AUA analysis](https://longbridge.com/en/news/286903126.md)
- [Dynatrace Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results | DT Stock News](https://longbridge.com/en/news/286242011.md)
- [Federal Realty to Webcast 2026 Investor Day Presentation | FRT Stock News](https://longbridge.com/en/news/286594264.md)
- [RenovoRx (RNXT) Q1 2026 Earnings Transcript](https://longbridge.com/en/news/286914537.md)